Literature DB >> 3611272

Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography.

R B Taylor, R R Moody, N A Ochekpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611272     DOI: 10.1016/0378-4347(87)80526-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.

Authors:  N A Helsby; S A Ward; G Edwards; R E Howells; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.

Authors:  S A Ward; W M Watkins; E Mberu; J E Saunders; D K Koech; H M Gilles; R E Howells; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

3.  The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.

Authors:  K Na-Bangchang; C Manyando; R Ruengweerayut; D Kioy; M Mulenga; G B Miller; J Konsil
Journal:  Eur J Clin Pharmacol       Date:  2005-07-23       Impact factor: 2.953

4.  Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.

Authors:  S Wanwimolruk; M R Thou; D J Woods
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

5.  Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.

Authors:  J Wangboonskul; N J White; F Nosten; F ter Kuile; R R Moody; R B Taylor
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.

Authors:  N A Helsby; S A Ward; R E Howells; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

7.  The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study.

Authors:  S A Ward; N A Helsby; E Skjelbo; K Brøsen; L F Gram; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

8.  Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.

Authors:  Y Wattanagoon; R B Taylor; R R Moody; N A Ochekpe; S Looareesuwan; N J White
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

9.  Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil.

Authors:  R McGready; K Stepniewska; E Seaton; T Cho; D Cho; A Ginsberg; M D Edstein; E Ashley; S Looareesuwan; N J White; F Nosten
Journal:  Eur J Clin Pharmacol       Date:  2003-08-30       Impact factor: 2.953

10.  The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.

Authors:  R McGready; K Stepniewska; M D Edstein; T Cho; G Gilveray; S Looareesuwan; N J White; F Nosten
Journal:  Eur J Clin Pharmacol       Date:  2003-08-30       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.